Patents
Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
02/2004
02/17/2004US6693192 Hypolipidemic and antioxidant morpholine derivatives
02/17/2004US6693123 (4-(3-pyridylaminomethylene)-2-phenylbenzoyl)-n -methylmethionine, methyl ester for example; restenosis, hyperplasia
02/17/2004US6693103 1,2,3,4-tetrahydro-2-thioxo-quinolinyl and 1,2,3,4-tetrahydro-2-oxo-quinolinyl derivatives as progesterone receptor modulators
02/17/2004US6692975 Compounds for use in the detection of preferential particles in sample
02/17/2004CA2152410C Mediators suitable for the electrochemical regeneration of nadh, nadph or analogs thereof
02/17/2004CA2124680C Piperazine derivatives as 5-ht1a antagonists
02/12/2004WO2003049702A3 Vanilloid receptor ligands and their use in treatments
02/12/2004US20040030141 Biphenyl derivatives substituted with an aromatic or heteroaromatic radical, and pharmaceutical and cosmetic compositions containing them
02/12/2004US20040029880 Anthranyl amides and their use as medicaments
02/12/2004US20040029837 Red fluorescence dyes; labels
02/12/2004US20040029720 Supported group 8-10 transition metal olefin polymerization catalysts
02/11/2004EP0859608B1 Treating niddm with rxr agonists
02/11/2004CN1474805A 2-amino-2-alkyl-5-heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
02/05/2004WO2004011447A2 Method for preparing fused oxazinones from ortho-amino aromatic carboxylic acid and a carboxylic acid in the presence of a sulfonyl chloride and pyridine
02/05/2004WO2004011423A2 Structural carotenoid analogs for the inhibition and amelioration of disease
02/05/2004WO2003084938A3 Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases
02/05/2004US20040024252 By reacting suitable amine acid compound with organic acid; for protecting organic materials, in particular synthetic polymers, reprographic materials or coating materials against oxidative, thermal or light-induced degradation
02/05/2004US20040024059 Novel pleuromutilin derivatives
02/05/2004US20040023960 Mammalian metabolites of the compound 2-(1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3- (4-fluoro) phenyl-4-(3-(5-oxo-1H,4H-1,2,4-triazolo) methylmorpholine which is a tachykinin receptor antagonist as antiemetics
02/05/2004US20040023956 New intermediates and synthetic methods for the stereospecific synthesis of oxazinone compounds, which are useful, for example, as antibiotics. The invention also pertains to novel olefinic oxazinone compounds, methods for
02/05/2004US20040023806 Agrochemicals in agriculture for controlling acarids and insects and for preventing the infestation of crop plants by phytopathogenic fungi.
02/05/2004US20040023290 Novel therapeutic agents that modulate enzymatic processes
02/05/2004CA2495167A1 Structural carotenoid analogs for the inhibition and amelioration of disease
02/04/2004EP1385971A2 Transformation of (di)amines in the presence of a lysine oxidase and a reducing agent
02/04/2004EP1385835A1 Benzoxazinone derivatives for use in the treatment of angiogenesis
02/04/2004EP1385818A2 Biurethane derivatives
02/04/2004EP1115697B1 Unsaturated hydroximic acid derivatives as parp inhibitors
02/04/2004EP0873109B1 Colorant for producing metameric effects on keratin fibres
02/04/2004CN1473034A Photo-labile pro-fragrance conjugates
02/04/2004CN1472205A Benzoxazine intermediate containing N-allyl and composition and preparation thereof
02/04/2004CN1472204A Condensed products of hydroxy aromatic mannich alkali and its use as ash disperser in lubricant composition
02/03/2004US6686466 Photochromic oxazine compounds and methods for their manufacture
02/03/2004US6686353 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
01/2004
01/30/2004CA2436347A1 Hydroxy aromatic mannich base condensation products and the use thereof as soot dispersants in lubricating oil compositions
01/29/2004US20040019111 A new use of existing pharmaceutical, a nonsteroidal antiinflammatory agents
01/29/2004US20040019072 Dimer-selective RXR modulators and methods for their use
01/29/2004US20040019038 Compounds useful as anti-inflammatory agents
01/28/2004EP1383760A1 Biarylcarboxamide compounds as apolipoprotein b inhibitors
01/28/2004CN1136203C Benzoxazine and penzothiazine derivatives and their use in pharmaceuticals
01/28/2004CN1136189C Substituted heterocyclic compounds, preparing method thereof and pharmaceutical composition containig them
01/27/2004US6683213 Chemical intermediates for pyridinedicarboxamide herbicides
01/27/2004US6683110 4-(4-ethoxyphenyl)-2-(n'-fluoren-9-ylidenehydrazino)-2-hydroxy -4-oxobutyric acid methyl ester; 2-(4-bromophenyl-amino)-5,5-dimethyl-4-oxohex-2-enoic acid methyl ester
01/27/2004US6683099 Substituted N,N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
01/27/2004US6683077 2-Amino-benzoxazinones for the treatment of viral infections
01/22/2004WO2004007407A2 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof
01/22/2004WO2004006850A2 3, 10, AND 12a SUBSTITUTED TETRACYCLINE COMPOUNDS
01/22/2004US20040014798 Skin disorders; hormone replacement therapy
01/22/2004US20040014774 Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
01/22/2004DE10228183A1 3,3,4,4-Tetrafluorcyclopentanverbindungen 3,3,4,4-tetrafluoroethane cyclopentadiene compounds
01/22/2004CA2492273A1 3, 10, and 12a substituted tetracycline compounds
01/21/2004EP1381592A1 1,4-disubstituted benzo-fused compounds
01/21/2004CN1469867A Novel phenylalanine derivatives
01/20/2004US6680317 N-(phenyl)-n*-(2-hydroxy-3-aminosulfonylphenyl)guanidine derivatives; chemokine inhibitors; respiratory, cardiovascular, rheumatic, brain, and nervous system disorders
01/15/2004WO2004005255A1 N-benzyl-3-phenyl-3-heterocyclyl-propionamide compounds as tachykinin and/ or serotonin reuptake inhibitors
01/15/2004WO2003099798A8 Morpholinylmethylureas ccr-3 receptor antagonist
01/15/2004WO2003084936A8 Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological
01/14/2004EP1380306A1 Remedies for psychoneurosis
01/13/2004US6677382 Halogenated oxyamines, used as enzyme inhibitors for prophylaxis of atherosclerosis and cardiovascular disorders, and as antilipemic agents
01/13/2004US6677380 Antilipemic agents such as 3(3-(4-chloro-3-ethyl-phenoxy)-phenyl)((3-(1,1,2,2 -tetrafluoroethoxy)phenyl)methyl))amino)-1,1,1-trifluro-2-propanthiol, used for prophlaxis of cardiovascular disorders and atherosclerosis
01/13/2004US6677379 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease
01/13/2004US6677378 Monoamine reuptake inhibitors for treatment of CNS disorders
01/13/2004US6677375 Substituted N,N-bis-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
01/13/2004US6677353 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
01/13/2004US6677332 Amide-substituted piperidine or azepine derivatives to treat drug abuse and tinnitus
01/08/2004WO2004002463A2 Method of promoting smoking cessation
01/08/2004US20040006077 Thiazine and oxazine derivatives as MMP-13 inhibitors
01/08/2004US20040006075 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments
01/08/2004CA2491549A1 Method of promoting smoking cessation
01/07/2004CN1466577A 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient
01/06/2004US6673372 Human immunodeficiency virus (hiv) treatment; reverse transcriptase inhibitor; x-ray powder diffraction and differential scanning calorimetry
01/02/2004EP1373237A1 Methods for producing oxirane carboxylic acids and derivatives thereof
01/02/2004EP1373232A1 Method of producing n-substituted 2,6-dialkyl morpholines
01/02/2004EP1373191A1 Acylated indanyl amines and their use as pharmaceuticals
01/02/2004EP1373188A1 Alanine 2,6-dialkoxyphenyl ester derivatives as hypnotics
01/01/2004US20040002539 Enzyme inhibitors; anticoagulants; blood collecting device
01/01/2004US20040002123 Detection of transmembrane potentials by optical methods
12/2003
12/31/2003WO2004000771A1 3,3,4,4-tetrafluorocyclopentane compounds, used as components of liquid crystal media
12/31/2003WO2004000322A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis
12/31/2003WO2004000321A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis
12/31/2003WO2004000230A2 Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders
12/31/2003WO2003072055A3 Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective mao inhibitors
12/31/2003CA2491210A1 Thiazine and oxazine derivatives as mmp-13 inhibitors for treating arthritis
12/31/2003CA2489815A1 Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders
12/30/2003US6670473 Inhibitors of nitric oxide synthase (nos)
12/30/2003CA2198637C Preparation of quaternized glycine nitriles
12/30/2003CA2078697C Imine compounds and their production
12/25/2003US20030236250 Antidepressants, anxiolytic agents, analgesics, antiinflammatory agents, reduce concentration of tachykinins
12/25/2003US20030236167 Novel herbicides
12/24/2003WO2003106441A1 Pharmaceutical salts of reboxetine
12/24/2003WO2003106440A2 Process for the synthesis of a benzamide derivative
12/24/2003WO2003105855A1 Mitotic kinesin inhibitors
12/24/2003CN1131856C 作为黄体酮受体调节剂的环硫代氨基甲酸酯衍生物 As cyclic thiocarbamate derivative of progesterone receptor modulators
12/23/2003US6667404 Retroviral protease inhibiting compounds
12/23/2003US6667308 Compounds for use as antidepressants, aphrodisiacs and adjunctive therapies in humans
12/23/2003US6667301 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders
12/18/2003WO2003104210A1 Selective chromophores
12/18/2003WO2003103656A1 O-substituted hydroxyaryl derivatives
12/18/2003WO2003072537A3 Selective protein tyrosine phosphatatase inhibitors
12/18/2003WO2003024401A3 Piperizinones as modulators of chemokine receptor activity
12/18/2003US20030232825 Benzoxazine derivatives and uses thereof
1 ... 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 ... 112